Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Minoxidil lowers blood pressure effectively but may cause side effects.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Diabetes often causes various skin problems and complications.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Women with PCOS have more emotional and body image issues than healthy women.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Tailor treatments for vitiligo to patient needs for best results.

The 25Up study collected extensive data on mental disorders and related factors in Australian twins and siblings to investigate the genetics of psychiatric illnesses.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Oral minoxidil effectively controls blood pressure quickly and safely.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.